These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 33777824)
41. Iodine excess and hyperthyroidism. Roti E; Uberti ED Thyroid; 2001 May; 11(5):493-500. PubMed ID: 11396708 [TBL] [Abstract][Full Text] [Related]
42. Preoperative plasmapheresis in patients with Graves' disease intolerant to antithyroid drugs. Apaydin T; Gogas Yavuz D Ther Apher Dial; 2021 Dec; 25(6):877-883. PubMed ID: 33661574 [TBL] [Abstract][Full Text] [Related]
43. Evaluation and Management of Children with Thyrotoxicosis. Leung AKC; Leung AAC Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552 [TBL] [Abstract][Full Text] [Related]
44. [Amiodarone and the thyroid gland]. Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257 [TBL] [Abstract][Full Text] [Related]
45. Amiodarone-induced thyrotoxicosis. A review. Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027 [TBL] [Abstract][Full Text] [Related]
46. Approach to the patient with amiodarone-induced thyrotoxicosis. Bogazzi F; Bartalena L; Martino E J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904 [TBL] [Abstract][Full Text] [Related]
47. Hyperthyroidism. De Leo S; Lee SY; Braverman LE Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492 [TBL] [Abstract][Full Text] [Related]
48. Fighting thyrotoxicosis with therapeutic plasma exchange: A case report. Valverde Márquez Á; Mories Álvarez MT; Villanueva Alvarado HS; Vivas Vaca XC; Delgado Gómez M Endocrinol Diabetes Nutr (Engl Ed); 2024 Apr; 71(4):177-180. PubMed ID: 38735679 [TBL] [Abstract][Full Text] [Related]
49. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism]. Gerber H; Noth D Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774 [TBL] [Abstract][Full Text] [Related]
50. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Maia AL; Scheffel RS; Meyer EL; Mazeto GM; Carvalho GA; Graf H; Vaisman M; Maciel LM; Ramos HE; Tincani AJ; Andrada NC; Ward LS; Arq Bras Endocrinol Metabol; 2013 Apr; 57(3):205-32. PubMed ID: 23681266 [TBL] [Abstract][Full Text] [Related]
51. [Amiodarone-induced thyrotoxicosis]. Bogazzi F; Tomisti L; Di Bello V; Martino E G Ital Cardiol (Rome); 2017 Mar; 18(3):219-229. PubMed ID: 28398380 [TBL] [Abstract][Full Text] [Related]
52. Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy. Claxton S; Sinha SN; Donovan S; Greenaway TM; Hoffman L; Loughhead M; Burgess JR Aust N Z J Surg; 2000 Mar; 70(3):174-8. PubMed ID: 10765898 [TBL] [Abstract][Full Text] [Related]
53. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Ross DS Endocrinol Metab Clin North Am; 1998 Mar; 27(1):169-85. PubMed ID: 9534035 [TBL] [Abstract][Full Text] [Related]
54. Review of oral cholecystographic agents for the management of hyperthyroidism. Tyer NM; Kim TY; Martinez DS Endocr Pract; 2014 Oct; 20(10):1084-92. PubMed ID: 25100369 [TBL] [Abstract][Full Text] [Related]